Trial Profile
Phase I Study of ASP2408 -Subcutaneous Single-dose, Placebo-controlled Study in Non-elderly Healthy Adult Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 2408 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 20 May 2014 New trial record